top of page

BHP Insights


ASCO 2026 Highlights: What Emerging Therapies and Shifting Standards Reveal About the Future of Cancer Care
ASCO 2026 marked a clear inflection point in oncology. Brooks Hill Partners breaks down the meeting's defining themes — from pan-KRAS inhibitors unlocking treatment in pancreatic cancer, to bispecific antibodies expanding immunotherapy's reach, and ADCs emerging as a cornerstone of next-generation combination strategies. Underlying it all: a growing imperative to translate scientific breakthroughs into globally equitable access.
Jun 18


The Role of Metabolism in Disease
Metabolism is a complex process that facilitates the breakdown of nutrients to generate energy and the production of molecules crucial for c
Dec 6, 2023


The Sims of Pharmaceutical Manufacturing
Okay, it’s 2009. The world as we know it is being utopianly replicated onto the grainy pixels of living room televisions across the world. Y
Nov 15, 2023


Beyond the Lab: Real World Evidence in Clinical Trials
Clinical trials, a massive hurdle in the biopharmaceutical world, are often the rate-limiting step in drug development. Not only are clinica
Nov 13, 2023


Harnessing the Power of Interleukins in Cancer Therapy
Cancer remains one of the most difficult challenges in modern medicine, and researchers have continually been exploring ways to combat this
Nov 9, 2023


Precision Medicine: The Future of Patient Care?
Precision medicine is an emerging field of medicine that aims to tailor disease treatment to people’s genes, environment, and lifestyle.
Jul 19, 2023
Interested in learning more?
bottom of page
